E-Prescribing System Market Scope
E-prescribing is a technology framework that allows physicians and other medical practitioners to write and send prescriptions to a participating pharmacy electronically instead of using handwritten or faxed notes or calling in prescriptions. It also helps in improving the safety and quality of patient care and enables access to patient history to ensure better care. E-prescribing also reduces the number of prescription errors attributed to bad handwriting or illegible faxes.
Attributes | Details |
---|
Study Period | 2019-2029 |
Base Year | 2023 |
Unit | Value (USD Million) |
Key Companies Profiled | GE Healthcare (United States), Epic Systems Corporation (United States), NextGen Healthcare (United States), athenahealth, Inc. (United States), Cerner Corporation (United States), Allscripts (United States), RelayHealth, LLC (United States), Henry Schein, Inc. (United States), Computer Programs and Systems, Inc. (United States) and DrFirst, Inc. (United States) |
CAGR | % |
The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing towards the production technologies, efficiency enhancement and product life. There is various growth opportunity in this market which is captured by leading players via tracking the ongoing process enhancement and huge invest in market growth strategies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global E-Prescribing System market throughout the predicted period.
GE Healthcare (United States), Epic Systems Corporation (United States), NextGen Healthcare (United States), athenahealth, Inc. (United States), Cerner Corporation (United States), Allscripts (United States), RelayHealth, LLC (United States), Henry Schein, Inc. (United States), Computer Programs and Systems, Inc. (United States) and DrFirst, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Surescripts-RxHub, LLC (United States), MEDITECH (United States), iMedX Inc. (United States), Practice Fusion, Inc. (United States) and eMDs, Inc. (United States).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global E-Prescribing System market by Type , by Application (Office-based physicians, Hospitals and Other) and Region with country level break-up.
On the basis of geography, the market of E-Prescribing System has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
region held largest market share in the year 2023.
Market Leaders and their expansionary development strategies
In October 2023, Surescripts, a leading E-Prescribing platform in the US, announced its acquisition of DrFirst, a competitor renowned for its medication intelligence solutions. This merger combines Surescript's vast network of pharmacies and healthcare providers with DrFirst's data analytics and clinical decision support tools, promising a more comprehensive E-Prescribing and medication management ecosystem.
In October 2023, eMeds, a UK-based E-Prescribing and repeat prescription ordering platform, partnered with Babylon Health to integrate Babylon's AI-powered virtual health consultations with eMeds' platform. This integration allows patients to receive prescriptions electronically after online consultations, further streamlining the healthcare experience.
The Centers for Medicare & Medicaid (CMS) has released a Request for Information (RFI) for Electronic Prescribing of Controlled Substances in Medicare Part D. On May 23, 2019, CMS published a final rule requiring that Part D plans adopt one or more real-time benefit tools (RTBTs) capable of giving prescribers clinically appropriate patient-specific real-time formulary and benefit information. This mandate is effective January 1, 2021.
Influencing Trend:
Adoption of Tools to Aid the E-Prescribing Of Controlled Substances and Growing Demand for Mobile-Based EHR Solutions
Market Growth Drivers:
Increasing Adoption of EHR Solutions, Increasing Focus on Reducing Medical Errors and Need To Curtail the Escalating Healthcare Costs
Challenges:
Lack of Technological Awareness among End Users, Financial Cost and Return on Investment (ROI) and Hardware and Software Selection
Restraints:
High Deployment Cost and Reluctance among Healthcare Professionals to Adopt E-Prescribing Solutions and Data Security and Workflow Issues
Opportunities:
Increased Adoption of Integrated Telehealth Solutions
Key Target Audience
E-Prescribing System Vendors, Software and Service Providers, Hospitals and Pharmacists, End-Use Industry and Others